Development of Pyro-Drive Jet Injector With Controllable Jet Pressure.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
07 2019
Historique:
received: 13 11 2018
revised: 13 02 2019
accepted: 22 02 2019
pubmed: 9 3 2019
medline: 28 7 2020
entrez: 9 3 2019
Statut: ppublish

Résumé

Various jet injectors have been developed and used for the effective and efficient administration of drugs. Jet injections overcome the limitations of other drug delivery methods, such as ablation, iontophoresis, electroporation, sonophoresis, and microneedles, because jet injection is not limited by the diffusion rates of different drugs. However, controlling the jet pressure during drug delivery is difficult with most conventional jet injectors. Efficacy evaluation of such devices on laboratory animals is strongly required before initiating human clinical trials, but minimal research has been performed for the device developments. Therefore, we developed jet injector devices based on pyrotechnics using 2 types of explosives with different burning rates; we call these pyro-drive jet injectors. The liquid jet pressure profile suggests that the penetration depth and injection volume for soft materials and skin tissue are controllable. Here, we propose the pyro-drive jet injectors as another candidate well-controlled jet injector for laboratory animals in drug discovery testing as well as human clinical use.

Identifiants

pubmed: 30849461
pii: S0022-3549(19)30139-X
doi: 10.1016/j.xphs.2019.02.021
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2415-2420

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Hiroshi Miyazaki (H)

Medical Device Division, R & D Headquarters, Daicel Corporation, Minato-ku, Tokyo, Japan.

Shingo Atobe (S)

Corporate Research Center, Daicel Corporation, Himeji, Hyogo, Japan.

Takamasa Suzuki (T)

Medical Device Division, R & D Headquarters, Daicel Corporation, Minato-ku, Tokyo, Japan.

Hiromitsu Iga (H)

Medical Device Division, R & D Headquarters, Daicel Corporation, Minato-ku, Tokyo, Japan.

Kazuhiro Terai (K)

Medical Device Division, R & D Headquarters, Daicel Corporation, Minato-ku, Tokyo, Japan. Electronic address: kz_terai@jp.daicel.com.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH